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SUMMARY
In the recent past there has been an increased emphasis on morphogenetic tissue research of
periodontal tissues. The aim of this study was to find qualitative and quantitative correlations in
distribution and appearance of growth factors/cytokines/defensins and apoptosis in periodontal
pathologies. Material and methods. Tissue was obtained from 5 controls and 6 chronical periodon-
titis patients 30-50 years of age referred to Latvian Institute of Stomatology. Histological investi-
gations were performed at the Institute of Anatomy and Anthropology of Riga Stradins University.
Results. Epithelial cells abundantly expressed IL10 in patients. The expression of β-defensins was
very variable in both sulcular and gingival epithelium. TUNEL positive cells were observed in
patients and control specimens with dominance in control group. Gingival epithelium showed mod-
erate expression of bFGF whereas few to moderate cells were positive for bFGF in sulcular
epithelium. Fibroblast growth factor receptor (FGF-1R) was abundant in gingival epithelium and in
connective tissue cells, but almost not detectable in sulcular epithelium. Insulin-like growth factor
receptor was not expressed in gingival epithelium and was weakly seen in basal layer of sulcular
epithelium. Basic nerve growth factor expresion in both types of epithelium was numerous to
abundant. Staining for the NGFR in the gingival epithelium was variable, with prevalence to be
moderate whereas sulcular epithelium was free from any factor immunoreactivity. Conclusion. 1.
Finding of apoptotic cells are variable and seems to correlate with the expression of defensins in
oral epithelium in patients with periodontitis. 2. FGFR was expressed more than the bFGF, but in
case with NGFR and bNGF situation was opposite. Although IGFRI was found in sulcular epithe-
lium with no expression in gingival one suggesting about stimulation in regeneration/adaptation in
periodontitis affected tissue. 3. The expression of growth factors and their receptors in sulcular
epithelium was lower than into the gingival epithelium and seems to be specific for periodontitis.
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INTRODUCTION
Morphogenetic tissue research in the craniofa-
cial region has become very actual nowadays. This
project is the first trial in Latvia that deals with ex-
amination of periodontal anomalies in molecular level.
Periodontal disease is one of the two major den-
tal diseases that affect human populations worldwide
at high prevalence rates (1, 2). An advanced peri-
odontal disease with deep periodontal pockets (6 mm
or more) affects 10% to 15% of adults worldwide
(3). The available evidence shows that important risk
factors for periodontal disease relate to poor oral
hygiene, tobacco use, excessive alcohol consumption,
stress, and diabetes mellitus.
Periodontitis is a chronic disease characterized by
the interaction between gram – negative bacteria and
the host inflammatory response, which results in tis-
sue destruction and tooth loss (4, 5, 6). Bacterial prod-
ucts act on the cellular constituents of the gingival tis-
sues, activating cellular processes that induce the de-
struction of connective tissues and bone (7, 8). Patho-
genic bacteria have virulence characteristics that can
prevent their efficient detection and elimination by the
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host, disable host cells and humoral factors, and di-
rectly adversely affect the tissues (8). Activated tis-
sue destructive cytokines is likely a major pathway for
connective tissue attachment loss and bone loss.
In inflamed periodontal periodontal lesions, vari-
ety of cytokines is produced by lymphocytes, mono-
cytes as well as by non-immune cells like fibroblasts,
epithelial and endothelial cells (9). Cytokines are
soluble, secreted glycoproteins which act as local sig-
naling molecules to control and coordinate cellular
behavior and function. Interleukin 10 (IL-10) is an
anti-inflammatory cytokine that plays a role in peri-
odontal disease by inhibiting synthesis of
proinflammatory cytokines such as IL1, IL6, IL8, and
tumor necrosis factor-α by monocytes and stimulat-
ing protective antibody production. It is found in in-
flamed periodontal tissues. Genetic polymorphisms in
the IL10 gene might be useful as a marker to diag-
nose susceptibility to periodontitis and may influence
the expression of the protein (10, 11).
Growth factors are generally considered to be a
subset of cytokines. They are biological mediators
which regulate connective tissue cell migration, pro-
liferation and synthesis of proteins and other compo-
nents of extracellular matrix. The response of target
cells to growth factors depends on the expression their
specific receptors. These receptors are transmem-
brane antigens which, on binding of the growth fac-
tors, produce a cascade of intracellular signals that
stimulate chemotaxis, cell growth, differentiation and
the production of extracellular matrix (12). The growth
factor receptors therefore also show of fundamental
importance in human periodontal growth and regen-
eration (13).
Epidermal growth factor (EGF) is a multifunc-
tional cytokine with a variety of biological effects in-
cluding stimulation of cell proliferation by binding to
its specific EGF receptor. It is a small molecular
weight polypeptide which is thought to have impor-
tant functions in epithelial growth and differentiation
and in wound healing. EGF exerts its action on cells
through binding to a cell surface receptor. EGF re-
ceptors were expressed at high levels on the cell sur-
face of basal cell layers of gingival epithelium (14).
Fibroblast growth factors (FGF) are a family of
at least 23 structurally related polypeptides that are
known to play a critical role in angiogenesis and mes-
enchymal cell mitogenesis. These growth factors bind
to four high affinity tyrosine kinase receptors desig-
nated as fibroblast growth factor receptors (15). Basic
fibroblast growth factor or fibroblast growth factor –
2 displays a wide variety of mesoderm and neuroec-
toderm derived cells and has a high efficiency of an-
giogenesis (16). In periodontium, FGF-2 is present in
the extracellular matrix, as well as in the cementum
and can function as a local factor at the site (17).
The presence of high affinity receptors for FGF-2
has been reported for many cell types (18). The num-
ber of sites per cell varies from 2000 to 120,000 ac-
cording to cell type studied.
The insulin like growth factors (IGF) is regulated
by a series of at least six different binding proteins
(insulin-like growth factor factor-binding proteins). As
with other antagonists, insulin-like growth factor-bind-
ing proteins bind to the insulin-like growth factors with
high affinity and typically may inactivate activity by
preventing ligand binding. There are two insulin like
growth factors – IGF1 and IGF2 both of which are
found in high concentration in serum. IGF-I is ca-
pable of preventing apoptosis in fibroblasts by acti-
vation of multiple signal transduction pathways (19).
IGF-1 has also been shown to regulate DNA and pro-
tein synthesis in periodontal ligament fibroblasts in
vitro and to enhance soft tissue wound healing in vivo
(20, 21). Studies have suggested variable responses
of periodontal tissues to IGF-1 upon anatomical site,
and a differential involvement of IGF-1 in periodon-
tal wound healing and regeneration (12). IGF-IR (in-
sulin growth factor 1) and PI3K (phosphoisositide 3-
kinase) are two signaling molecules that could medi-
ate IGF-I induced cell survival via common or inde-
pendent pathways (22).
Nerve growth factor (NGF) appears to have mul-
tiple neuronal and non-neuronal functions in peripheral
tissues. NGF is produced by target tissues and is re-
quired for development and maintenance of sympa-
thetic sensory neurons. NGF regulates responsive cells
by binding to high affinity (Type 1) and low affinity
(Type 2) surface receptors. Only Type 1 receptor has
been shown to internalize bound NGF, thus triggering
biological responses (23, 24). Nerve growth factor
(NGF) is a representative of neurotrophins responsible
for the differentiation and survival of neurons (25, 26).
NGF activates 2 different receptor classes: the tro-
pomyosin-related kinase (Trk) family of receptor ty-
rosine kinases (TrkA, TrkB, and TrkC) and the p75
receptor, a member of the tumor necrosis factor re-
ceptor superfamily. Neurotrophins regulate both cell
death and cell survival through activations of Trk re-
ceptors and/or p75 neurotrophin receptor. It has been
reported that neurotrophins are also produced from non-
neuronal cells, such as leukocytes, osteoblasts, or fi-
broblasts, and act in many other ways on non-neu-
ronal cells. It has been found that sulcular epithelium
have intense p75-NGFR staining.
Antimicrobial peptides belong to first line of host
defense mechanisms against infections in epithelial
tissue. As part of innate immunity, defensins playing
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an important role in maintaining tissue integrity in oral
health are small cationic cysteine-rich antimicrobial
peptides (27) and have a broad spectrum antimicro-
bial activity against gram-positive and gram-negative
bacteria, fungi and viruses (28). They function by as-
sociation with the anionic microbial surface, and then
aggregate to form pores or disrupt microbial mem-
branes, although new evidence suggests possible ad-
ditional cytoplasmic targets. Defensins are localized
in different sites in gingiva, suggesting that they are
likely to serve different roles in several ecological
niches of the periodontium (29). Human defensins
are classified into two subgroups: α defensins and β
defensins. Polimorphonuclear leucocytes express α
defensins and β defensins are expressed by mucosal
epithelial cells (30). It has been reported that α and β
defensins are localized in different parts of gingival
epithelium. β defensins are expressed in the oral and
sulcular stratified epithelium of gingival, but α
defensins are expressed in the junctional epithelium
(31, 32).
Apoptosis or programmed cell death is an impor-
tant determinant of the life span of cells in regenerat-
ing tissues; defined by distinct morphological and bio-
chemical features (33, 34). It can be observed under
both physiological and pathological conditions and plays
an important role in the process of morphogenesis and
homeostasis. The apoptotic cells shrinking and loss of
cell-cell junctions results in detachment from the adja-
cent cells. Cells undergoing apoptosis are recognized
by condensation of chromatin, the degradation of DNA
into oligonucleosome-sized fragments, and the forma-
tion of plasma and nuclear membrane blebs (35). Even-
tually the cell breaks apart to form so-called apoptotic
bodies. Apoptosis is one of the mechanisms involved
in the pathogenesis of periodontitis thus regulates a
cell turnover in gingival tissue.
The aim was to find qualitative and quantitative
correlations in distribution and appearance of
interleukin-10 (IL-10), antimicrobial peptides – β-
defensins, growth factors:epidermal growth factor
(EGF), basic fibroblast growth factor (bFGF) and its
receptor one (FGF-R1), insulin-like growth factor re-
ceptor one (IGF-R1) and basic nerve growth factor
(bNGF) and its receptor (NGFR), and also apoptosis
in healthy and diseased periodontal tissues.
MATERIALS AND METHODS
The tissue samples obtained were identified as
minimally inflamed gingival tissues or chronical peri-
odontitis on the basis of clinical record, radiographs
and macroscopical examination. Minimally inflamed
gingiva (clinically healthy gingiva) was defined by ab-
sence on bleeding on gentle probing, no clinical signs
of inflammation and a probing depth of 3 mm or less.
Chronical periodontitis specimens were obtained from
patients with a probing depth 5 mm and more and with
an evidence of resorbtion of the alveolar bone. Tissue
was obtained from 5 controls and 6 chronical periodon-
titis patients referred to Latvian Institute of Stomatol-
ogy, Department of Periodontology for periodontal
treatment. 30-50 year olds age group was chosen.
Samples were taken during a routine periodontal flap
surgery with an internal bevel incision and immediately
fixed in 10% phosphate buffered formalin. Histologi-
cal investigations were performed at the Institute of
Anatomy and Anthropology of Riga Stradins Univer-
sity. Fixed periodontal tissue was embedded in paraf-
fin and cut in 5 µm thin sections. After they were pro-
ceeded for interleukin-10 (Rabbit Policlonal to IL-10 /
ab34843, w.d.1:400, Abcam, England), β-defensins
(Anti-human β-Defensin 2 Antibody, AF 2758, w.d.
1:100, R&D systems, Deutchland), epidermal growth
factor (Mouse anti-human  to EGFR / M3563, w. D.
1:150, DakoCytomation, Denmark), basic fibroblast
growth factor (Rabbit polyclonal to bFGF, w.d. 1:200,
Abcam, England) and its receptor one (Rabbit
polyclonal to FGFR1 / ab 10646, w.d. 1:100, Abcam,
England), insulin- like growth factor receptor one (Anti-
human IGF-I R Antibody, AF-305-NA, w.d. 1:100, R&D
systems, Deutchland) and basic nerve growth factor
(Rabbit polyclonal to NGF / ab 6199, w.d. 1:500, Abcam,
England) and its receptor (Anti-human NGFR p75 /
M3507, w.d.1:150, DakoCytomation, Denmark) by
using of biotin-streptavidin immunohistochemistry
(IMH) (36). Also apoptosis were detected by using of
TUNEL kit (37).
Routine staining for hematoxylin and eosin was
performed. Distribution of factors and substances was
determined semi quantitatively by counting of posi-
tive structures in visual fields (0/+ – occasional, + –
few, ++ – moderate, +++ – numerous positive struc-
tures in visual fields, ++++ – abundance) (38).
Permission of Ethical Committee of Riga Stradins
University was received for the work with human
material.
RESULTS
From controls only two responded to the com-
mon healthy tissue picture of periodont. In other cases
morphological changes of controls were similar to
those in periodontitis. In some cases hyperplasia of
gingival epithelium and vacuolization of epithelial cells
in sulcular epithelium was observed (Figure 1). Tis-
sue demonstrated also infiltration with inflammatory
cells – macrophages and lymphocytes (Figure 2).
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Epithelial cells abundantly expressed IL10 in pa-
tients (Figure 3) whereas in control group numerous
positive cells were found. Also variable expression of
IL-10 in connective tissues was seen both in patients
and in controls. The expression of IL-10 was abundant
in sulcular epithelium (pocket epithelium) and moderate
in oral gingival epithelium (Table 1) (Table 2).
The expression of β-defensins was very vari-
able in both sulcular (pocket) and gingival epithelium.
There were even cases when no staining in sulcular
epithelium was found, but averagely few positive cells
were detected. Generally β-defensin in gingival epi-
thelium was of occasional expression till numerous
positive structures found (Figure 4).
TUNEL positive cells were observed in patients
and control specimens with dominance in control
group. Number of apoptotic cells in gingival epithe-
lium often was higher than in sulcular, but common
number of apoptotic cells was moderate (Figure 5).
Epidermal growth factor was regionally detected
in basal layer of gingival epithelium only in one
chronical periodontitis case (Figure 6).
Gingival epithelium showed moderate expression
of bFGF (Figure 7) and weaker staining of the in-
flammatory cells and connective tissues. Few to mod-
erate cells were positive for bFGF also in sulcular
epithelium. Fibroblast growth factor receptor (FGF-
1R) was abundant in gingival epithelium (Figure 8)
and in connective tissue cells, but almost not detect-
able in sulcular epithelium.
Insulin-like growth factor receptor was not ex-
pressed in gingival epithelium and was weakly seen
in basal layer of sulcular epithelium (Figure 9).
Basic nerve growth factor expresion in both types
of epithelium was numerous to abundant. It also was
found moderately expressed by inflammatory cells.
Neuroendocrine cells marked by bNGF were detected
in the gingival epithelium of two controls.
Gingival epithelium basal layer was strongly
stained for nerve growth factor receptor while only
moderate nerve fibers showed staining around blood
vessels (Figure 10). Staining for the NGFR in the gin-
gival epithelium was variable, with prevalence to be
moderate whereas sulcular epithelium was free from
any factor immunoreactivity.
DISCUSSION
Growth factors initiate many of the events asso-
ciated with turnover, repair and regeneration of peri-
odontal tissues. The corresponding receptors are thus
of fundamental importance in maintaining periodontal
Fig. 6. Expression of EGFR in the basal
layer of gingival epithelium in patient.
Immunohystochemistry, x400.
Fig. 2. Infiltration of connective tissues with
inflammatory cells in patients with peri-
odontitis. Heamatoxylin and eosin, x400.
Fig. 1. Sulcular and gingival epithelium with
hyperplasia of basal cells in patients with
periodontitis. Heamatoxylin and eosin, x400.
Fig. 4. Epithelial cells showing IL10 im-
munoreactivity in patients. Immuno-
hystochemistry, x250
Fig. 3. Epithelial cells showing IL10
immunoactivity in patients. Immuno-
hystochemistry, x200.
Fig. 5. Numerous apoptotic cellsin gin-
gival epithelium in control. TUNEL, x250.
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integrity and mediating periodontal wound healing, but
their expression in human gingival is not well defined.
The most dominant expression of growth factors and
their receptors in our study was seen in gingival epi-
thelium in the specimens of periodontitis group. Nor-
mal gingival tissues expresses relatively lower amounts
of the growth-factor receptors in contrast with inflamed
or regenerating tissues where increased growth fac-
tor and their receptor prevalence are found (14). The
biological properties of bFGF acting on variety of mes-
enchymal cell types may suggest that bFGF applica-
tion is of great advantage for active induction of peri-
odontal regeneration consisting of not only connective
tissue regeneration, but also osteogenesis and
cementogenesis. In such a way we suggest about in-
flammation that stimulates expression of the same
growth factors and their receptors. However, inter-
esting is the abserved correlations between appear-
ance of factor and receptors. So, FGFR were expressed
more than the same bFGF, but in case with NGFR and
bNGF situation was opposite.
The expression of FGFRI was reported to be
higher in hyperplasic gingival tissue than in normal gin-
giva. An additional mechanism regulating FGF activity
involves heparin or heparin sulfate proteoglicans, mol-
ecules which facilitate ligand receptor activation. Bind-
ing of ligand to FGFRI induces receptor dimerisation
and activation of the receptor tyrosine kinase domain
by autophosphorilation, followed by activation of down-
stream effector (39). Higher expression of FGFRI
compairing to bFGF also can be due to possible ap-
pearance of acidic FGF (aFGF) in periodontal tissues.
The FGFRI binds also to aFGF (40).
Beside of NGF role in maintenance and survival
of peripheral and central nervous system and devel-
opment of neuronal cells, it also has important func-
tions on nonneuronal cells. It is also an autocrine sur-
vival factor for memory of B lymphocytes (41). The
effect of NGF is mediated by activation of two dif-
ferent classes of plasma membrane receptor, high-
affinity Trk tyrosine kinase receptors (TrkA, TrkB,
TrkC) and low affinity p75 neutrophin receptors that
form complexes. P75 receptors have a much wider
distribution than any of Trk receptors in various cell
types. Due to the relatively higher levels of p75, the
majority of NGF binding is to p75 receptors, with the
Trk receptors becoming low affinity. It is approved
that p75 receptor can serve as putative cell marker
in oral epithelium as it is expressed in the basal cell
layer of both tips of the papillae and deep rete ridges
in oral epithelium. Activation of receptor p75 without
co-expression of Trk receptors, initiates apoptosis
Fig. 8. Abundant expression of FGFR1
from sulcular epithelium and moderate
from gingival epithelial cells in patients.
Immunohystochemistry, x250.
Fig. 7. bFGF expression from gingival
epithelial cells in control. Immuno-
hystochemistry, x250.
Fig. 9. Expression of IGFR1 from the the
basal layer of sulcular epithelium in pa-
tients. Immunohystochemistry, x250.
Fig. 10. Abundant expression of NGF
from epitheliocytes of gingival epithelium
in patients. Immunohystochemistry, x250.
Fig. 12. Neuroendocrine cells marked by
bNGF in the gingival epithelium of con-
trols. Immunohystochemistry, x400.
Fig. 11. Abundant expression of NGF
from epitheliocytes of gingival epithelium
in patients. Immunohystochemistry, x250.
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(42). Thus, the cell-inducing or cell-survival actions
of NGF are strongly dependent on the relative ex-
pression of p75 and Trk receptors on the target-cell
populations. Absence of NGFR expression in sulcular
epithelium correlates also with indistinct apoptosis in
our patients and together with rich appearance of
bNGF let us suggest about the common stimulating
role of this factor in adaptation processes during pe-
riodontitis.
In general, IGFRI is the most important media-
tor of effects of IGFs on mitogenesis, apoptosis, cell
motility, tumorogenesis and metastasis. IGFRI is a
receptor that plays critical role in signaling cell sur-
vival and proliferation. Overexpression of IGFRI in-
duces transformation, and activation blocks pro-
grammed cell death (apoptosis). Transcription of the
IGFRI gene is upregulated by PDGF and bFGF (43).
IGFRI is expressed in most body tissues and levels
of IGFRI mRNA are modulated in a number of physi-
ological and pathological states, including changes in
the levels of various circulating and locally acting
growth factors (44).
IGFRI may have only a limited effect on peri-
odontal regeneration in vivo and as data shows play
a more prominent part in the formation of new bone
at later stages of periodontal wound healing process,
as IGF enhances DNA syntesis in osteoclasts and
has a significant role in osteogenesis (12). There may
be a factors (inflammation, etc.) present that sup-
press the expression of the receptor as it seems in
our patients with periodontitis.
The variable amount of antimicrobial peptides and
inflammatory markers probably do not directly de-
pend on inflammation, as different expression of IL10
and defensins was seen in both types of epithelium.
Rather defensins appearance correlates with level of
apoptosis and perhaps some other not cleared yet
factor. Our observations are also not consistent with
other findings reporting that apoptosis was a preva-
lent phenomenon in human clinically healthy gingival
tissues that might be changed in diseased conditions
and in accordance to the role of defensins that de-
fend the tissues because inflammation was seen in
almost all patients and control tissues.
CONCLUSIONS
1. Finding of apoptotic cells are variable and
seems to correlate with the expression of defensins
in oral epithelium in patients with periodontitis.
2. FGFR was expressed more than the bFGF,
but in case with NGFR and bNGF situation was op-
posite.
Although IGFRI was found in sulcular epithe-
lium with no expression in gingival one suggesting
about stimulation in regeneration/adaptation in peri-
odontitis affected tissue.
3. The expression of growth factors and their
receptors in sulcular epithelium was lower than into
the with gingival epithelium and seems to be specific
for periodontitis.
Fig. 13. Abundant expression of NGFR in the basal layer of
gingival epithelium, Immunohystochemistry, x250.
Table 1. Expresion of Interleukin-10, β-defensins; apoptotic





IL-10 ++ ++++ 
β-defensins 0/+ / + / ++ / +++ 0/+ / +  
TUNEL 0/+ / + / ++ / +++ + 
 
Table 2. Growth factor and their receptors expression in gin-
gival and sulcular epithelium
0/+ – occasional positive structures in visual field
+ – few positive structures in visual field
++ – moderate positive structures in visual field
+++ – number of positive structures in visual field
++++ – abundance of positive structures in visual field
Underlined is the most often seen appearance of positive
structures.
0/+ – occasional positive structures in visual field
+ – few positive structures in visual field
++ – moderate positive structures in visual field
+++ – number of positive structures in visual field
++++ – abundance of positive structures in visual field






Epidermal growth factor 
EGF 
+ - 
Fibroblast growth factor 
bFGF 
+ / ++ + / ++ 





Insulin like growth factor 
receptor IGF-1R 
- 0/+ / + 
Nerve growth factor bNGF +++ / ++++ +++ 
Nerve growth factor rece-
ptor NGFR 
0/+ / + / ++ / +++ - 
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